How Emerging Biomarkers in Non-Small Cell Lung Cancer are Driving New and More Innovative Targeted Treatments
Lung cancer is one of the most common tumors and about 228,000 new cases will be diagnosed in the...
Lung cancer is one of the most common tumors and about 228,000 new cases will be diagnosed in the...
Written by Jaclyn Fink, Data Quality Assurance Analyst, Prognos Health.
On World Cancer Day we recognize the countless brave people who have been affected by cancer and...
Read an interesting article by Jason Bhan, M.D., Chief Medical Officer of Prognos, here on on PM360.
A Follow Up to “Biomarker Testing in Non-Small Cell Lung Cancer“ By Melissa Leonhauser, General...
Clinical Diagnostic Data for Omnichannel HCP Promotion Marketing: Part Two We’re excited to share...
By Bill Bowman, Clinical Solutions Architect
A 5 Part Series By Matt Apprendi, VP of Digital Products We’re excited to write about one of the...
Diabetes is one of many conditions where lab testing plays a critical role.